Table 2—

General linear model with change in cholesterol from baseline as the dependent variable

FactorP value
Gender0.257
Age (years)0.630
Thiazolidinedione*0.004
Thiazolidinedione dose0.767
Days exposed to TROG0.788
Concurrent HMG-CoA reductase inhibitor*0.001
Concurrent insulin0.076
Concurrent sulfa0.893
Concurrent metformin0.686
  • *

    * No statistical interaction detected between thiazolidinedione and HMG-CoA reductase inhibitor.